Dialysis world news


Sanofi announces changes at Genzyme - Boston Globe PDF Print
Boston Globe
Genzyme's current oncology, biosurgery, and renal operations will be integrated into Sanofi businesses, the new owner said. Sanofi did not say if that move would involve job cuts. Genzyme currently employs about 4500 workers in Massachusetts and 10000

...

 
Corwith man on dialysis faces questionable future - Mason City Globe Gazette PDF Print
Mason City Globe Gazette
Kris Buehner Becky and John Babcock with the expensive dialysis machine that is keeping John alive in their Corwith home. KRISTIN BUEHNER/The Globe Gazette CORWITH - Dialysis patient John Babcock faces a questionable future following notice from his

...

 
Silchar Medical College lacks key departments - Assam Tribune PDF Print
Assam Tribune
These include neurological, nephrology, burns unit and plastic surgery. Many memoranda have been submitted to the State Government but there has been no result. To discuss all this, a meeting was organised in the town jointly by the Ellora Merchant

...

 
Affymax files for approval of kidney disease drug - Forbes PDF Print
Forbes
It is intended to treat anemia in patients who have chronic kidney failure and are on dialysis. Affymax and Takeda previously called the drug candidate Hematide. Takeda, a Japanese drugmaker, has marketing rights outside the US Affymax, of Palo Alto, ...
Affymax and Takeda Announce the Submission of a New Drug Application for

...

 
APOL1 Donor Gene Linked to Renal Graft Survival - Doctors Lounge PDF Print
Doctors Lounge
Significantly shorter renal allograft survival is seen in recipients of kidneys donated by African-American donors with two apolipoprotein L1 gene risk variants compared to patients receiving a kidney from a donor with zero or one risk variant,

...

 
<< Start < Prev 871 872 873 874 875 876 877 878 879 880 Next > End >>

Page 880 of 2630
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.